Noninvasive means of diagnosing liver fibrosis in hepatitis C

Brazilian Journal of Infectious Diseases

Volumn 11, Issue 6, 2007, Pages 530-534

  Gonçales, Eduardo Sellan Lopes ^a   Angerami, Adriana Flávia Feltrim ^a   Gonçales Jr , Fernando Lopes ^a  

^a UNIVERSITY OF CAMPINAS   (Brazil)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA 2 MACROGLOBULIN; APOLIPOPROTEIN A1; ASPARTATE AMINOTRANSFERASE; BILIRUBIN; GAMMA GLUTAMYLTRANSFERASE; HAPTOGLOBIN;

ALGORITHM; ARTICLE; ASPARTATE AMINOTRANSFERASE TO PLATELET RATIO INDEX; CLINICAL ASSESSMENT TOOL; CLINICAL TRIAL; DIAGNOSTIC ACCURACY; DIFFERENTIAL DIAGNOSIS; ELASTOGRAPHY; ENZYME BLOOD LEVEL; FIBROTEST; HEPATITIS C; HUMAN; INTERMETHOD COMPARISON; LIVER CIRRHOSIS; LIVER EXAMINATION; LIVER FIBROSIS; NON INVASIVE MEASUREMENT; PROTEIN BLOOD LEVEL; SCORING SYSTEM; SENSITIVITY AND SPECIFICITY; STANDARDIZATION; THROMBOCYTE COUNT; ULTRASOUND SCANNER;

EID: 41149144537     PISSN: 14138670     EISSN: None     Source Type: Journal    
DOI: 10.1590/S1413-86702007000600001     Document Type: Article

References (15)

1. Perrault J., McGill D.B., Ott B.j., Taylor W.F. Liver biopsy: complications in 1000 inpatients. Gastroenterology 1978;74:103-6.
2. Gunneson T.J., Menon K.V., Wiesner R.H., et al. Ultrasound-assisted percutaneous liver biopsy perfomed by a physician assistant. Am J Gastroenterol 2002;97:1472-5.
3. Wong J.B., Koff R.S. Watchful waiting with periodic liver biopsy versus immediate empirical therapy for histologically mild chronic hepatitis C. A cost-effectiveness analysis. Ann Intern Med 2000;133:665-75.
4. Colloredo G., Guido M., Sonzogni A., Leandro G. Impact of liver biopsy size on histological evaluation of chronic viral hepatitis: the smaller the sample, the milder the disease. J Hepatol 2003;39:239-44.
5. Poniachik J., Bernstein D.E., Reddy K.R., et al. The role of laparoscopy in the diagnosis of cirrhosis. Gastrointest Endosc 1996; 43:568-571.
6. Wai C.T., Greenson J.K., Fontana R.J., et al. A simple noninvasive index can predict both significant fibrosis and cirrhosis in patients with chronic hepatitis C. Hepatology 2003;38:518-26.
7. Poynard T., McHutchison J., Manns M., et al. Biochemical surrogate markers of liver fibrosis and activity in a randomized trial of peginterferon alfa-2b and ribavirin. Hepatology 2003;38:481-92.
8. Transient elastography: a new surrogate marker of liver fibrosis influenced by major changes of transaminases. Journal of Viral Hepatitis 2007;14:360-9.
9. Diagnosis of hepatic steatosis and fibrosis by transient elastography in asymptomatic healthy individuals: a prospective study of living related potencial liver donors. Journal of Gastroenterol 2007;42:382-8.
10. Usefulneness of elastometry in evaluating the extents of liver fibrosis in hemophiliacs coinfected with hepatitis C and human immunodeficiency virus. Hepatology research 2006;35:135-9.
11. Features associated with success rate and performance of fibroscan measurements for the diagnosis of cirrhosis in HCV patients: a prospective study of 935 patients. Journal of Hepatology 2007; 46:628-34.
12. Transient elastography: a valid alternative to biopsy in patients with chronic liver disease. Journal compilation 2006;24:513-8.
13. Do not trivialize the Fibroscan examination, value its accuracy. Journal of Hepatology 2007;46.
14. Sebastiani G., Vario A., Guido M., et al. Stepwise combination algorithms of non-invasive markers to diagnose significant fibrosis in chronic hepatitis C. Journal of Hepatology 2006;44:686-93.
15. Castéra L., Vergniol J., Foucher J., et al. Gastroenterology 2005;128:343-50.